Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Jul 1;155(7):819-825.
doi: 10.1001/jamadermatol.2019.0032.

Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma

Emily Stamell Ruiz  1 , Pritesh S Karia  1   2 , Robert Besaw  1 , Chrysalyne D Schmults  1
Affiliations
Comparative Study

Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma

Emily Stamell Ruiz et al. JAMA Dermatol. .

Abstract

Importance: Brigham and Women's tumor classification (BWH) better predicts poor outcomes than American Joint Committee on Cancer (AJCC) 7th edition (AJCC 7). AJCC 8th edition (AJCC 8) has not been evaluated.

Objectives: To compare BWH and AJCC 8 tumor classifications for head and neck cutaneous squamous cell carcinoma (HNCSCC).

Design, setting, and participants: A total of 459 patients with 680 HNCSCCs in this cohort study were staged via BWH and AJCC 8 classifications and poor outcomes (ie, local recurrence [LR], nodal metastasis [NM], disease specific death [DSD], and overall survival [OS]) were compared. The study was carried out at a single academic tertiary care center in Boston, Massachusetts.

Main outcomes and measures: Distinctiveness (outcome differences between tumor class), homogeneity (outcome similarity within tumor class), monotonicity (outcome worsening with increasing tumor class), and C statistic.

Results: A total of 680 HNCSCCs in 459 patients were included in this study, of which 313 (68%) were men with the mean (SD) age of 70.2 (12.7) years. The AJCC 8 (T3/T4) and BWH (T2b/T3) high tumor classes accounted for 121 (18%) vs 63 (9%), 17 (71%) vs 16 (70%), and 11 (85%) vs 12 (92%) of total cases, metastases, and deaths, respectively. The AJCC 8 T2 and T3 comprised 23% of cases and had statistically indistinguishable outcomes. The BWH had higher specificity (93%) and positive predictive value (30%) for identifying cases at risk for metastasis or death. C statistics showed BWH to be superior in predicting NM and DSD (P = .01 and P = .005, respectively), but there was no difference for LR and OS.

Conclusions and relevance: Lack of distinction between AJCC T2 and T3 resulted in a 23% subset of HNCSCCs with significant risk of metastasis and death-too large of a group for routine nodal staging or consideration of adjuvant therapy. The BWH identifies the same number of poor outcomes in a 9% subset of HNCSCCs, thus minimizing inappropriate upstaging of low-risk disease.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure.
Figure.. Cumulative Incidence Function Curves
A, Local recurrence; B, nodal metastasis; and C, disease-specific death. D, Kaplan-Meier survival curves for overall survival by Brigham and Women’s Hospital (BWH) tumor classification for cutaneous squamous cell carcinomas of the head and neck (HNCSCC). E, Cumulative incidence function curves for local recurrence; F, nodal metastasis; and G, disease-specific death. H, Kaplan-Meier survival curves for overall survival by American Joint Committee on Cancer 8th Edition (AJCC 8) tumor classification for HNCSCC. Figures E-H are adapted from figures previously published in JAMA Dermatology.
See this image and copyright information in PMC

References

    1. Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol. 2013;68(6):957-966. doi:10.1016/j.jaad.2012.11.037 - DOI - PubMed
    1. Eigentler TK, Leiter U, Häfner HM, Garbe C, Röcken M, Breuninger H. Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study. J Invest Dermatol. 2017;137(11):2309-2315. doi:10.1016/j.jid.2017.06.025 - DOI - PubMed
    1. Brantsch KD, Meisner C, Schönfisch B, et al. . Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713-720. doi:10.1016/S1470-2045(08)70178-5 - DOI - PubMed
    1. Mourouzis C, Boynton A, Grant J, et al. . Cutaneous head and neck SCCs and risk of nodal metastasis - UK experience. J Craniomaxillofac Surg. 2009;37(8):443-447. doi:10.1016/j.jcms.2009.07.007 - DOI - PubMed
    1. Jambusaria-Pahlajani A, Kanetsky PA, Karia PS, et al. . Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol. 2013;149(4):402-410. doi:10.1001/jamadermatol.2013.2456 - DOI - PubMed

Publication types